Skip to product information
1 of 1

MULTI SCIENCES

Human IGFBP-1 ELISA Kit Distributor

Human IGFBP-1 ELISA Kit Distributor

SKU:EK1255

Regular price Send Inquiry
Regular price Sale price Send Inquiry
Sale Sold out
View full details

Product Details

Human IGFBP-1 ELISA Kit Distributor

CatNum EK1255
Product Name Human IGFBP-1 ELISA Kit
Customs Name Human IGFBP-1 ELISA Kit
Application ELISA
Reactivity Human
SDS SDS - EK1255
Assay Type Sandwich ELISA
Suitable Sample Type serum, plasma, cell culture supernates
Format 96-well strip plate
Storage 4℃ (unopened)standard stored at -20℃, others stored at 4℃ (opened)
Shipping Condition 4℃
Sample Volume 10 μl
Sensitivity 0.93 pg/ml
Standard Curve Range 31.25 - 2000 pg/ml
Spike Recovery Range 83% - 118%
Mean Spike Recovery 1.01
CV of Intra plate 4.8% - 5.2%
CV of Inter plate 3.0% - 5.0%
Components 96-well polystyrene microplate coated with a monoclonal antibody against IGFBP-1
Human IGFBP-1Standard, lyophilized
IGFBP-1 Detect Antibody
Standard Diluent
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
Washing Buffer (20×)
Plate Covers
Describtion This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human IGFBP-1. The Human IGFBP-1 ELISA is for research use only. Not for diagnostic or therapeutic procedures.
Insulin-like growth factor-binding protein 1 (IGFBP-1) also known as placental protein 12 (PP12) is a protein that in humans is encoded by the IGFBP1 gene. The protein binds both insulin-like growth factors (IGFs) I and II and circulates in the plasma. Binding of this protein prolongs the half-life of the IGFs and alters their interaction with cell surface receptors. IGFBPs modulate the biological activities of IGF proteins.Post-translational modifications of IGFBP, including glycosylation, phosphorylation and proteolysis, have been shown to modify the affinities of the binding proteins to IGF. High IGFBP-1 may be a marker of a catabolic state. Research shows that women with higher IGFBP-1 were more likely to have a low relative muscle mass. Higher IGFBP-1/IGF-1 serum ratio is significantly associated with poor prognosis in nasopharyngeal carcinoma(NPC) patients. Local IGFBP1 level was reported to affect the development of coronary artery plaque.